1. Home
  2. PCRX vs EIM Comparison

PCRX vs EIM Comparison

Compare PCRX & EIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.96

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Municipal Bond

EIM

Eaton Vance Municipal Bond

HOLD

Current Price

$9.68

Market Cap

511.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
EIM
Founded
2006
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
511.7M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
EIM
Price
$25.96
$9.68
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$32.86
N/A
AVG Volume (30 Days)
870.0K
215.2K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
4.32%
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$716,791,000.00
N/A
Revenue This Year
$6.24
N/A
Revenue Next Year
$9.53
N/A
P/E Ratio
$55.21
N/A
Revenue Growth
3.14
N/A
52 Week Low
$18.17
$8.61
52 Week High
$27.64
$10.51

Technical Indicators

Market Signals
Indicator
PCRX
EIM
Relative Strength Index (RSI) 60.19 30.95
Support Level $25.48 $9.63
Resistance Level $27.16 $9.77
Average True Range (ATR) 1.02 0.05
MACD 0.01 -0.02
Stochastic Oscillator 67.69 15.15

Price Performance

Historical Comparison
PCRX
EIM

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About EIM Eaton Vance Municipal Bond

Eaton Vance Municipal Bond Fund is a non-diversified closed-end management investment company. It consists of Municipal bond fund, California municipal bond fund, and New York municipal bond fund. The company's investment objective is to provide current income exempt from regular federal income tax, alternative minimum tax, and taxes in specified states. Its investment plan is to invest in higher quality bonds.

Share on Social Networks: